INTRODUCTION
Kinetic analysis and mathematical modeling of plasma bilirubin-IXa (bilirubin)l disappearance curves have provided important insight into the complex processes of hepatic bilirubin transport and metabolism (2) . Although in early studies large doses of unlabeled pigment had been used (3), the subsequent availability of isotopically labeled bilirubin ofhigh specific activity (4, 5) permitted experiments to be performed under more physiological conditions using tracer doses of the pigment. These investigations (2, (6) (7) (8) (9) (10) (11) , which provided a measure of the rates of hepatic bilirubin clearance and bilirubin production, resulted in the formulation of a three-compartment model that adequately described the metabolism of unconjugated bilirubin. In addition, more complex models have been proposed to accommodate the bilirubin fractions derived from turnover ofhepatic heme and hemoproteins (12) (13) (14) . These models have been used to interpret data derived from plasma radiobilirubin disappearance studies in various human disorders associated with unconjugated hyperbilirubinemia (13, (15) (16) (17) (18) (19) .
All of these investigations were carried out in humans and hence validation of the proposed compartmental models was restricted to analysis of data obtained from a single compartment, e.g., plasma radiobilirubin disappearance. Indeed, in only two subjects were data obtained from bile, namely in an individual with an external bile fistula (8) and in a patient with Gilbert's syndrome in whom bile was collected from the duodenum (13) . To minimize the assumptions required in formulating a model and thus to reduce inherent ambiguities and uncertainties, it is desirable to verify experimentally as many of the proposed compartments as possible. Although use of experimental animals permits serial sampling of bile and liver, animal studies with radiolabeled bilirubin have been carried out only in intact rats to define plasma disappearance (20, 21) and in isolated rat liver perfused with an erythrocyte-containing medium to determine bilirubin kinetics in perfusate and bile (22) . With rose bengal dye, on the other hand, experiments in rats have been reported in which plasma, liver, and intestinal contents were sampled serially (23) .
In the present study a new and more sensitive procedure for quantitation of plasma bilirubin has been used, obviating the use of the Weber-Schalm solventpartition method (24) that has been widely adopted (8, 22, 25) despite its documented inaccuracies (8, (26) (27) (28) . Using this procedure we have examined the hepatic transport kinetics of radiobilirubin in 30 intact rats and developed a compartmental model that described all experimental data obtained from plasma, liver, and bile. The proposed model, which was validated by kinetic studies in isolated rat liver perfused with a heme-free fluorocarbon medium, differs from existing models in predicting that a fraction of bilirubin glucuronides in the liver undergoes deconjugation with return of unconjugated bilirubin so formed to the plasma. This prediction was verified experimentally by measurement of 14CO2 production in rats infused with bilirubin [14C]monoglucuronide.
METHODS

Chemicals and radiolabeled pigments
Bilirubin consisting ofat least 94% IXa isomer was obtained from Koch-Light Lab., Ltd. (Colnbrook, Buckinghamshire, U. K.) or Porphyrin Products (Logan, Utah) and recrystallized before use (29) 
[3H]Bilirubin (sp act 43 ,uCi/4tmol) prepared biosynthetically (4) from the bile of rats injected with 8-amino [3,5-3H] levulinic acid (1.2 Ci/mmol, New England Nuclear, Boston, Mass.) was stored in vacuo in the dark and recrystallized to constant specific activity before use. BilirubinIXa 1-0-acyl ,8-D-mono-[U-_4C]glucuronide (BMG) was prepared by incubating bilirubin-IXa and UDP-[U-_4C]glucuronic acid (231 mCi/mmol, New England Nuclear) with digitonin-activated liver microsomes from rats pretreated with phenobarbital (administered for 7 d in drinking water, 0.1% wt/vol). Details of the incubation, extraction, and chromatographic isolation of BMG have been described (30, 31) . The pigment was quantitated spectrophotometrically assuming E450 60 x 103 liter-mol-' * cm-' for BMG in methanol.
The yield of labeled BMG was 30% and the preparation contained 90-93% authentic BMG in addition to 4% BDG and 3-6% nonradioactive unconjugated bilirubin (32) . When eluted from silica gel with methanol and promptly evaporated to dryness and stored in the dark under argon at -20°C, BMG preparations were stable for at least 2 d. Immediately before injection, the BMG was dissolved directly in normal rat serum, whereas [3H]bilirubin was dissolved in a small volume of 0.1 M NaOH and then added to 14 vol of rat serum. All procedures were carried out in subdued light to minimize photodegradation of pigments.
[3H]Bilirubin kinetics -intact rats [3H]Bilirubin kinetics -isolated perfused liver
Isolated rat livers were perfused with a hemoglobin-free medium consisting of a perfluorochemical emulsion as oxygen-carrier in a Krebs-Ringer bicarbonate solution (Fluosol-43, Alpha Therapeutic Corp., Los Angeles, Calif.). In addition fraction V bovine serum albumin (1% wt/vol, Sigma Chemical Co., St. Louis, Mo.), 22.3 ,uM sodium taurocholate (Calbiochem-Behring Corp., American Hoechst Corp., San Diego, Calif.) and penicillin (100 U/ml) were included in the medium. This solution was thoroughly mixed, passed though a 10 ,(M Millipore filter (Millipore Corp., Bedford, Mass.), and the pH adjusted to 7.45 with 0.1 M NaHCO3. In preliminary studies it was ascertained that the constituents of Fluosol-43 did not bind bilirubin.
The perfusion system, housed in a thermostatically controlled lucite cabinet, contained 50 Amol/min per g liver) (36) . Bile flow decreased from 1.52+0. 17 ,ul/min per g liver (1.02+0.06 ml/h) during the control period to 1.07±0.09 ,ul/min per g liver after 2-h perfusion.
Analytical procedures
Total radioactivity was measured in aliquots of whole plasma .ul) after mixing with 1 ml Soluene-350 (Packard Instrument Co., Downers Grove, Ill.), bleaching with 0.2 ml isopropyl alcohol and 0.2 ml 30% hydrogen peroxide, and adding 10 (37) , [3H] bilirubin radioactivity migrated as a single band and cochromatographed with authentic bilirubin. The yellow bilirubin band was scraped from the plate and extracted twice with a total of 4 ml chloroform. The absorption of the supernatant fluid at 454 nm was measured and the solution then evaporated. The residue was dissolved in Soluene-350 and radioactivity was determined after preparation of the sample as described above. Specific activity ofthe extracted bilirubin was computed, and the total [3H]bilirubin radioactivity in the original plasma sample was obtained by multiplying the specific activity by the amount ofcarrier added. The contribution of native unlabeled bilirubin in the plasma sample was assumed to be negligible in relation to the amount of carrier added.
An aliquot of each dose of [3H]bilirubin injected into intact animals or the liver perfusion medium was analyzed by the cetrimide extraction and TLC procedure as described above. When the computed specific activity ofthe extracted bilirubin was multiplied by the amount of pigment in the dose plus the added carrier, the isotope content of authentic [3H]bilirubin was found to be consistently lower (6.6+0.3%) than the total radioactivity of the injected dose. This difference appeared to be the result of degradation of a small fraction of the added pigment to labeled diazo-negative derivatives (4, 38) , occurring during the brief period when the pigment was dissolved in 0.1 M NaOH before its addition to serum (4, 38, 39) . A difference between the computed isotope in authentic [3H]bilirubin and total radioactivity was found in all plasma samples collected from intact rats that had been given a tracer pulse of [3H] bilirubin. This appeared to reflect the presence in the administered dose of labeled degradation products coinjected with the authentic [3H]bilirubin, but direct quantitation of these degradation products in the small collected plasma samples was beyond the resolution of the analytical methods available. Although it is theoretically possible that the fraction of total label in plasma that corresponded to labeled bilirubin degradation products might also have included some labeled conjugated bilirubin, none could be identified by TLC of plasma extracts.
Radioactivity was determined in aliquots of the administered dose of [3H]bilirubin, plasma, liver, and bile after preparation of the samples using Soluene-350, isopropylalcohol, hydrogen peroxide, and Dimilume as described above. Radioactive counting was performed in a liquid scintillation spectrometer (Beckman LS-250, Beckman Instruments, Fullerton, Calif.). All samples were counted for 40 ,000 counts or 10 min to ensure an error in net count rate of <1%. Counting efficiency determined with a [3H] toluene internal standard was used to correct counts to disintegrations per minute. All data obtained from plasma, liver, and bile were expressed as a fraction oftotal 3H-radioactivity (disintegrations per minute) in the administered dose.
Data analysis
Preliminary kinetic profiles of the data from intact animals and isolated perfused liver were obtained by resolving the plasma (total 3H-activity or 3H-unconjugated bilirubin) and perfusate (total 3H-activity) disappearance curves into their exponential components. The data, expressed as a fraction of dose per milliliter of plasma or perfusate, were fitted to sums of two and three exponential functions by a nonlinear least squares method, weighted by the reciprocal of the square of concentration (40) . The function used took the form: n p(t) = I Aj exp(-Xjt), (1) J=1 where p denotes plasma concentration; t, time; Aj, intercept of the j-th exponential; and xi, decay rate coefficient of the j-th exponential.
From the parameters of the exponential fit, initial distribution volume (V) (milliliters) was computed from the equation:
J=1 and the total plasma clearance rate (C, milliliters per minute) was estimated as follows:
To characterize the kinetics of hepatic bilirubin transport, a variety of models were examined. This was accomplished by testing visually the degree of fit between the experimental data and numerically integrated differential equations describing the model (achieved by adjustment offractional transfer constants). In this search, the Euler method (41) was used, and implemented on a desk-top computer (HP 9825A HewlettPackard Co., Palo Alto, Calif.) interfaced with a HP 9872A plotter. In keeping with current concepts ofbilirubin metabolism, four distinct pools were considered in intact rats: plasma, extravascular (intra-and extrahepatic), hepatic, and biliary.
The models were examined for their ability to fit the experimentally obtained data on plasma disappearance, hepatic content, and biliary excretion of injected [3H]bilirubin. The most appropriate model was selected and then tested for its ability to fit the data obtained from isolated perfused liver.
In the final stage of fitting the model to data from both intact animals and perfused liver, an objective criterion, sum of squares weighted by reciprocal variances, was employed using the HP 9825A desk-top computer. Sensitivity analysis was also performed, which delineates the degree of certainty with which each parameter was estimated with respect to the minimization of the sum of squares. The sensitivity is expressed as fractional second difference of the sum of squares when the parameter changes by 1%. The greater the sensitivity, the more confidence can be placed on the parameter and the less uncertainty is involved in its estimation.
Statistical methods.
Results are shown throughout as mean and standard errors. Student's t test was used to estimate significance of the differences between mean values.
Deconjugation of BMG in vivo
Because the model that fitted the experimental data suggested that a portion of bilirubin glucuronides formed in the liver was hydrolyzed, an experiment was devised to test this possibility directly. The experimental approach was based on the assumption that "4C-labeled glucuronic acid hydrolyzed from bilirubin ['4C]monoglucuronide (prepared biosynthetically from UDP-[U-4C]glucuronic acid) would be metabolized in the liver with formation of 14CO2 and "4C-labeled xylulose. The latter compound then would be further degraded in the hexose monophosphate shunt to "4CO2 (42) . Hence, for each mole of BMG hydrolyzed, between 1 and 6 mol of '4CO2 would result. The experiments were performed in rats with external biliary drainage to exclude the possibility of intestinal deconjugation and reabsorption of 14C.
The jugular vein and bile duct were cannulated in four Sprague-Dawley rats (225±5 g). The animals were placed in separate glass metabolic chambers and 5% glucose in aqueous 0.15 M NaCl was infused continuously at 1.5 ml/h. After a control period of 30 min, 0.08 ,umol [14C]BMG in 0.7 ml rat serum was injected intravenously as a bolus. Bile and expired "4CO2 were collected for 20 min intervals over the 1st h and 30 min intervals for a further 3 h. Cumulative excretion of radioactivity in bile samples was determined in a liquid scintillation spectrometer (counting efficiency, 94%) and expressed as a fraction of the injected dose.
The "4CO2 collection system was similar to that described previously (43) . Air from the animal chamber, drawn under vacuum, was dried with Aquasorb (Mallinckrodt, St. Louis, Mo.), and the "4CO2 trapped in two tubes placed in series, each containing 4 ml of ethanolamine:methoxyethanol (1:1, vol/ vol). 1-ml aliquots of this solution were added to 4 ml methanol, 1 ml methoxyethanol, and 12 ml Liquiflor-toluene (New England Nuclear), and the radioactivity measured with a counting efficiency of 90%. Efficiency of the CO2 train was 95%, as determined by the recovery of a known amount of"4CO2 released in the animal chamber. "4CO2 production was expressed as a percentage of the administered radioactivity. The extent of bilirubin deconjugation was calculated on the assumption that the liberated labeled glucuronic acid moiety was completely metabolized to 6 mol of "4CO2; this yielded a minimal estimate of bilirubin glucuronide hydrolysis. (including labeled degradation products) were compared, the clearance rate of the latter was considerably slower (Table I) Bile. In three rats with an external bile fistula, bile flow throughout the 120 min of the experiment remained constant and averaged 1.7, 1.7, and 1.5 ml/h. With the tip of the 10-cm bile cannula placed <1 cm from the liver, the extrahepatic transit time elapsing before sample collection was -1 min. After injection of [3H]bilirubin, extraction and TLC of labeled pigments in bile showed that at least 98% of all radioactivity was present in conjugated bilirubin; labeled bilirubin degradation products could not be detected. Cumulative excretion in bile of the injected dose of [3H]bilirubin was 94.0±0.2% in 2 h, which compared favorably with previously published findings (44, 45) .
Compartmental model of [3H]bilirubin kinetics. The compartmental model shown in Fig. 2 Fig. 2 , the dashed arrow r7 = 0). However, as shown in Fig. 3A , the plasma [3H]bilirubin curve predicted by the model when r7 = 0, was unable to simulate the observed data beyond 20 min, and overall the simulated liver and bile curves exhibited lower values than the observed data. It was evident that to achieve a decreased terminal rate of plasma unconjugated bilirubin disappearance, recycling of some conjugated bilirubin into the plasma unconjugated bilirubin compartment (Pu, Fig. 2 ) was necessary. This could not be achieved, however, by assuming that the process of conjugation was directly reversible because, under these circumstances, the terminal phase of the plasma curve appeared similar to that in Fig. 3A . A variety of alternative connections between compartments containing conjugated bilirubin and Pu were explored (e.g., Lc --Pu), and the best results ( Fig. 3B) were obtained by introducing the deconjugation pathway represented in Fig. 2 by the dashed arrow r7.
Because the data for plasma and liver were obtained in intact rats but those for bile in bile fistula animals, duplicate simulations were carried out such that the presence or absence of an enterohepatic circulation of conjugated bilirubin was considered for plasma and liver data (i.e., insertion of an additional compartment between B and Pc; not shown in Fig. 2 ). It was evident that inclusion of an enterohepatic circulation in the model did not influence the fit for either the plasma or hepatic compartments during the 120-min experimental period. This is consistent with earlier direct observations that conjugated bilirubin is not reabsorbed from the intestine (46, 47) .
The small proportion (6.6%) of bilirubin degradation products in the injected dose of [3H]bilirubin disappeared slowly from plasma (Table I, Fig. 3 ) and none could be detected in bile. The ultimate mode of elimination of this fraction was not investigated, since the behaviour of these bilirubin degradation products (Fig. 2) . Fig. 3A illustrates the poor computer fit to the experimental data when the deconjugation pathway is omitted from the model (r7 = 0). Fig. 3B shows the fit obtained when deconjugation (r7) is incorporated into the model.
has no relevance to the model representing physiologic bilirubin transport (shown in Fig. 2 , enclosed by continuous line). The fractional rate constants and distribution volumes are presented in Table II . The results indicate that net hepatic extraction is less than initial uptake (r3), confirming previous observations in humans (8) .
The mean fraction r&/(r8 + r4) was 0.80, and thus of the bilirubin entering the hepatic pool, 20% refluxed to plasma unchanged, whereas 80% underwent conjugation. The hepatic pool of unconjugated bilirubin aver- (Fig. 2) to the experimental data obtained in intact rats (Fig. 3B ) and isolated perfused rat liver (Fig. 4) Fig. 4 . When the perfusate total radioactivity data were fitted to the sum of two or three exponentials (Table III) (0) is expressed as a fraction of the dose per milliliter perfusate (calculated on the basis of a volume of distribution of 17 ml; see Table III ) and excretion of radioactivity in bile (0) as cumulative fraction of the dose. The continuous lines represent the curves computed from the compartmental model which includes r7 and is shown in Fig. 2 .
using intact rats (Tables I and III , P < 0.01). Recovery of injected radioactivity in bile, 86±4% after 1 h and 90+4% after 2 h, was somewhat less (4% at 2 h) than that observed in intact animals. Compartmental model of [3H]bilirubin kinetics. Perfusate and bile data obtained from the isolated liver readily fitted the compartmental model derived using intact rats (Fig. 2) . Only minor changes in the graphical presentation were necessary in order to fit the perfused liver data to the in vivo model, namely (a) the total simulated perfusate radioactivity concentration in 1/ml (i.e. Pn/Vn + Pj/Vu + PJVC) was compared to the experimental data, and (b) modification of various fractional rate constants due to the characteristics of the perfused liver system (i.e., r2 = 0 assuming a negligible extravascular pool, and r13 = 0 since bilirubin degradation products were neither detectable in bile nor had any other exit route). The resulting relative accumulation of radiolabeled bilirubin degradation products in the perfusion medium may account, at least in part, for the slower disappearance oftotal radioactivity from perfusate than from plasma of the intact animals (Tables I and III) . The fractional rate constants and distribution volumes are shown in Table II .
Radioactivity in perfusate and bile ofthe isolated perfused livers (Fig. 4) was compatible with the curves predicted from the intact animal model (Fig. 2 , which includes r,). Since this conformity added further support to the model-derived concept that a fraction of hepatic conjugated bilirubin is deconjugated and returned to the plasma-unconjugated bilirubin compartment, an experiment was performed to directly verify the occurrence of deconjugation. 
After a tracer dose of bilirubin [14C]monoglucuronide had been injected intravenously into four rats, 84±3% of the radioactivity was recovered in bile in 2 h and during the subsequent 1 h an additional 1-2% was excreted. Maximal excretion of radioactivity in bile occurred in the first 20 min after injection. In addition, 6 .9±0.5% of the injected dose of radioactivity was recovered in 3 h as expired G4CO2, reflecting metabolic degradation of the labeled glucuronic acid moiety to 14CO2. Radiolabeled CO2 was evident in the breath within 20 min of labeled BMG administration, reached a maximum after min, and declined steadily during the ensuing 3 h.
DISCUSSION
Plasma radiobilirubin disappearance in intact rats and perfusate radiobilirubin disappearance in isolated perfused rat liver experiments were best described by the sum ofthree exponentials (Tables I and III) . The initial volume of bilirubin distribution computed from the three exponentials (Table I ) was comparable to the plasma volume estimated by independent methods (48) . The findings are in agreement with those reported in humans (6, 8, 13) and are consistent with the prevailing concept that transport of bilirubin across the liver plasma membrane is a bidirectional process (8, 48) . Experimental evidence that unconjugated bilirubin refluxes from liver to plasma has recently been obtained in studies using the radiolabeled pigment precursors 8-aminolevulinic acid (12, 13, 22) , heme (49) , and biliverdin (50) . In the present animal experiments, an average of 20% of bilirubin entering the liver refluxed back into plasma, whereas in humans a value of 37% has been reported (8) . This difference in plasma reflux is probably insufficient to account for the much faster plasma disappearance of pigment in rats (t1/2 of initial exponential = 42 s, Table I ) as compared to humans (18 min) (8) . Additional factors such as species differences in albumin binding ofbilirubin (51) , relative liver size, and hepatic blood flow probably also play a role.
In the present experiments, a methodological problem was encountered which, while recognized previously (38, 52) , has not been examined in detail in studies of bilirubin plasma disappearance and hepatic transport. Before radiobilirubin can be added to serum for injection, the crystalline pigment has to be dissolved in an aqueous solvent at alkaline pH which inevitably results in breakdown of a small amount of the pigment to labeled diazo-negative degradation products of undetermined structure (4, 38, 39) . Although this can be minimized by exclusion of light and by limiting pigment exposure to the alkali to a few seconds, analysis of the injected pigment by the cetrimide extraction procedure and TLC indicated that in the present experiments an average of 6.6% of the radiobilirubin had been degraded in the process ofpreparing it for injection. The pigment breakdown products apparently are poorly excreted by the liver, since none could be detected in bile and recovery of total radioactivity in bile fell 6% short ofthat injected. It was. to be expected, therefore, that the labeled degradation products would disappear from plasma more slowly than authentic radiobilirubin. This was indeed the case, as the half-life of the terminal exponential of total radioactivity (including degraded bilirubin) was significantly longer (P < 0.001) than that of authentic [3H]bilirubin (Table I, Fig. 3 ). This observation implies that in studies of bilirubin kinetics, analytical methods should be used that specifically measure radiobilirubin rather than merely extractable radioactivity. For example, in a previous investigation of plasma bilirubin kinetics in rats (20) , which used a conventional solvent extraction procedure (8, 24) , the half-life of the terminal exponential was disproportionately longer in relation to those of the first two exponentials than in the present study (Table I ). In calculating certain model-independent parameters such as bilirubin production rate and hepatic bilirubin clearance (2, 7-10) from kinetic studies in humans, apparent slowing of the terminal exponential of plasma disappearance due to the presence of labeled bilirubin degradation products would result in substantial underestimation of the actual values. In the present studies in intact animals, we therefore expressed plasma disappearance in terms of authentic radiobilirubin rather than total radioactivity. Although the mode of elimination of the water-soluble bilirubin degradation products was not investigated, they probably are excreted preferentially in the urine (4, 38) .
When the model-derived curves were applied to the experimental data obtained by analysis ofplasma, liver, and bile, initial difficulties were encountered in obtaining a satisfactory fit (Fig. 3A) . To achieve complete compliance, it was necessary to modify the model so that a fraction ofbilirubin conjugated in the liver be deconjugated and returned to the plasma unconjugated bilirubin compartment (Figs. 2 and 3B ). The occurrence of deconjugation has been verified directly by the demonstration that injected bilirubin [14C]monoglucuronide is partially hydrolyzed giving rise to the appearance of 14CO2 in expired air. Although in Fig. 2 , this process of deconjugation is depicted as occurring in plasma (r7), it is unlikely to occur at this site for the following reasons. First, no conjugated bilirubin is detectable in normal plasma (53) . Second, hepatic uptake of conjugated bilirubin from plasma is more rapid than that of unconjugated pigment (21) . Third, estimation of the apparent volume of distribution of the plasma conjugated bilirubin compartment (P,) yielded an improbably high value of 166 ml (Table II) . Fourth, bilirubin glucuronides added to plasma in vitro do not undergo hydrolysis (31) . Thus, to resolve this apparent discrepancy in the model, a location for bilirubin deconjugation was sought which is adjacent to the plasma compartment permitting rapid equilibration with it. Since the liver was a prime candidate for this, the model was modified (Fig. 5) to include a hepatic compartment, Lcc, representing that fraction of conjugated bilirubin exchanging rapidly with Pc, as distinct from LCB which contains conjugated bilirubin destined solely for biliary excretion. When this expanded model was tested with the experimental data, relative to the original model (Fig. 2) the fit was unchanged. Inasmuch as compartments Pc and LCC could not be distinguished kinetically, it is likely that under physiological conditions Pc and LCC represent a single compartment reflecting deconjugation of conjugated bilirubin in the liver with subsequent transfer ofthe unconjugated pigment to plasma (Fig. 5) . Although by no means unique, this model is the simplest of the many examined which was compatible with all of the available data and consistent with the notion of hepatic deconjugation.
The concept that a fraction ofbilirubin conjugated in the liver subsequently undergoes deconjugation is by no means novel. It was first suggested by the observation in Gunn rats that intravenous injection of normal rat bile containing conjugated bilirubin led to an increase in the plasma unconjugated pigment level (54, 55) . More recently, it was found that infusion of BDG into Gunn rats resulted in biliary excretion ofabout 6% BMG (31) . Moreover, in normal rats infused with BMG dual-labeled in the glucuronosyl and tetrapyrrole moieties, recovery in bile of the label contained in the glucuronosyl group consistently was less than that in the tetrapyrrole moiety (31) . The present findings document that a major fraction of the isotope not appearing in bile is eliminated in the form of exhaled labeled CO2. This deconjugation process appears to take place largely or exclusively in the liver, as the experiments were performed in animals with an external bile fistula, thereby excluding the intestinal tract as a site of deconjugation. We have not investigated the mechanism(s) of hepatic pigment deconjugation, but have eliminated reversible transglucuronidation (i.e., 1 mol BDG + 1 mol bilirubin 2 mol BMG) as a possible mechanism by experiments in Gunn rats (31) . The abundance of /3-glucuronidase in the liver (56, 57) and the association of 8-glucuronidase activity with bilirubin granules in cholestatic liver (54) suggest that this enzyme may be involved in the process. However, inasmuch as neither the distribution nor the transport of conjugated bilirubin in the hepatocyte are understood, the physiological role of this hydrolytic enzyme in pigment deconjugation remains conjectural. The present findings collectively provide direct validation of the proposed compartmental model for bilirubin transport in the liver (Fig. 5) . They suggest that hepatic deconjugation of a minor fraction of bilirubin glucuronides is a normally occurring metabolic event. This observation may offer a plausible explanation for the frequent occurrence of increased plasma levels ofunconjugated bilirubin in patients with cholestasis (53) . It further indicates that a portion ofthe BMG excreted in normal bile (58-61) may be derived from hydrolysis of BDG. It is possible that hepatic deconjugation is a more general mechanism, involving other endogenous substances and xenobiotics that form glucuronides. Indeed, preliminary findings with the morphine antagonist naltrexone suggest that it undergoes partial hepatic deconjugation.3 APPENDIX The mathematical model corresponding to Fig. 2 is described by the following set of ordinary linear differential equations with constant coefficients: Pn = -(r11 + rl3)Pn + r12Ln, (1) Ln= rlPn -r12Ln, ( 2) E = r2Pu -r,E, (3) Pu= r1E -(r2 + r3)Pu + r4Lu + r7Pc, -(r5 + r7)Pc, (6) Le= rL,Lu -(r6 + r9)L, + r5Pc,
1 = rgLc -r1OD1, (8) D5 = rio(D4 -D5),
B = r1oD5. (10) with the initial conditions:
3 V. Li6ko. Unpublished observation.
P"(O) = 1 -f
P"(0) = f (12) and all others zero initial conditions. Entities designated by capital letters are total fractional amounts in the appropriate compartments.
